EGFR and glioblastoma: Due to the prominent role of EGFR in controlling the cell cycle and its correlation with poor prognosis, EGFR and EGFRvIII have recently emerged as promising therapeutic targets for the treatment of GBM [24], [28], as has PI3K [29]–[31].